V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 190009057 | 190004809 | 1.57 | 54.4 | Palliative (P) | 2018-10-31 | 2018-10-31 | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | 02 | null | OXALIPLATIN + MDG | 100942308 |
| 190009058 | 190004810 | 1.66 | 74 | null | null | 2019-07-04 | EW EuroEwing 2012 Arm B VDC | 01 | N | EURAMOS TRIAL | 100979612 |
| 190009060 | 190004811 | 1.79 | 116.2 | Palliative (P) | 2020-10-04 | 2020-10-16 | Capecitabine + Oxaliplatin 21day | 02 | Y | CISPLATIN + RT | 101543193 |
| 190009061 | 190004812 | 1.68 | 69.3 | Palliative (P) | 2018-09-17 | 2018-09-18 | Trial Unspecified | 02 | N | CISPLATIN + RT | 100885096 |
| 190009063 | 190004813 | 1.61 | 102 | Palliative (P) | null | 2017-06-27 | Cisplatin + Radiotherapy | 02 | N | GEMCITABINE | 101806747 |
| 190009069 | 190004814 | 1.64 | 106.3 | Palliative (P) | null | 2020-01-20 | GemCarbo Days 1+8 | null | null | MAP + MIFAMURTIDE | 100528654 |
| 190009074 | 190004815 | 1.69 | 63.5 | Curative (C) | 2017-10-21 | 2017-10-21 | GEMCARBO | N | N | CISPLATIN + GEMCITABINE | 100895919 |
| 190009075 | 190004816 | 0 | 62.5 | Curative (C) | 2016-12-07 | 2016-12-07 | EW Rel rEECur Topotecan/Cyclophosphamide | 01 | N | CISPLATIN + GEMCITABINE | 100596210 |
| 190009078 | 190004817 | 1.61 | 82 | null | 2018-03-02 | 2018-03-08 | Carboplatin AUC 2 - 5 | N | N | CARBOPLATIN | 101767807 |
| 190009084 | 190004818 | 1.82 | 88.8 | Palliative (P) | null | 2018-02-14 | Cisplatin + Paclitaxel | 02 | null | CISPLATIN + GEMCITABINE | 100122474 |
| 190009100 | 190004819 | null | 65 | Neo-adjuvant (N) | 2018-10-03 | 2018-10-03 | CARBOPLATIN + GEMCITABINE | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 101380047 |
| 190009108 | 190004820 | 1.78 | 60.58 | Neo-adjuvant (N) | 2019-12-19 | 2019-12-20 | Gemcitabine 1000mg/m2 D1 8 15 | 02 | N | CISPLATIN + GEMCITABINE | 101069425 |
| 190009114 | 190004821 | 1.74 | 56.3 | null | 2019-03-08 | 2019-03-16 | MAP | N | N | CAPECITABINE + MITOMYCIN | 100708674 |
| 190009117 | 190004822 | null | 78.2 | 03 | null | 2019-01-09 | null | null | null | CAPECITABINE + IRINOTECAN | 101452979 |
| 190009119 | 190004823 | 1.77 | 92.2 | Disease modification (D) | 2020-04-03 | 2020-04-03 | Cisplatin + Gemcitabine (D 1 & 8) | 02 | N | ENZALUTAMIDE | 100889289 |
| 190009122 | 190004824 | 1.85 | 57.5 | 02 | 2020-09-07 | 2020-09-07 | Doxorubicin + Olaratumab | 02 | null | GEMCARBO | 100531019 |
| 190009136 | 190004825 | 1.89 | 57.75 | Palliative (P) | 2018-05-18 | 2018-05-18 | EURAMOS TRIAL | 02 | null | CISPLATIN + DOCETAXEL | 100257224 |
| 190009138 | 190004826 | 1.61 | 73.2 | null | 2019-08-14 | 2019-12-20 | STS NON-RHABDO EPSSG 2005 VDC/IE | 02 | null | BEVACIZUMAB | 100191597 |
| 190009142 | 190004827 | 1.8 | 50.6 | Neo-adjuvant (N) | 2018-03-04 | 2018-03-06 | CARBOPLATIN + GEMCITABINE | 02 | N | DOCETAXEL | 101237553 |
| 190009149 | 190004828 | 0 | 36.5 | Palliative (P) | 2017-11-11 | 2017-11-12 | NB HRNBL-1 ch14.18/CHO only (trial) | 02 | N | BLEOMYCIN | 101726065 |
| 190009152 | 190004829 | null | 83.2 | Palliative (P) | 2019-04-21 | 2019-06-06 | NB HRNBL-1 COJEC Ind COURSE C | 02 | null | AVELUMAB | 100349515 |
| 190009154 | 190004830 | null | 38.8 | Adjuvant (A) | 2019-03-13 | 2019-03-20 | CISPLATIN + RT | 02 | N | CISPLATIN | 100324943 |
| 190009155 | 190004831 | 1.6 | 54.4 | null | 2017-07-12 | 2017-11-17 | Folfirinox | N | N | CAPECITABINE + OXALIPLATIN | 100425885 |
| 190009159 | 190004832 | 1.73 | 57.3 | null | 2014-10-19 | 2014-10-19 | null | 02 | null | NIVOLUMAB | 101118304 |
| 190009160 | 190004833 | 1.79 | 65.9 | Adjuvant (A) | null | 2018-07-28 | CARBOPLATIN + ETOPOSIDE | 02 | null | CAPECITABINE + CARBOPLATIN | 101084493 |
| 190009164 | 190004834 | 1.74 | 161.4 | Palliative (P) | 2020-07-14 | 2020-08-03 | Carboplatin + Etoposide iv&po | 01 | N | GEMCITABINE | 100979202 |
| 190009190 | 190004835 | 0 | 46 | Curative (C) | 2018-08-19 | 2018-09-13 | Carboplatin AUC 6 - 10 | 02 | N | CARBOPLATIN | 101769791 |
| 190009192 | 190004836 | 1.8 | 111 | Curative (C) | 2019-09-19 | 2019-11-05 | VAI (Ifos 3g/m2) | 01 | N | CISPLATIN + GEMCITABINE | 100316469 |
| 190009193 | 190004837 | 1.38 | 75.8 | null | 2020-05-02 | 2020-05-07 | Capecitabine + Oxaliplatin 21day | Y | N | CISPLATIN + ETOPOSIDE | 101185191 |
| 190009196 | 190004838 | 1.57 | 11.5 | Palliative (P) | null | 2022-03-07 | Carboplatin AUC 6 - 10 | 02 | null | CARBOPLATIN | 100289747 |
| 190009199 | 190004839 | 1.62 | 53.2 | Curative (C) | 2021-05-31 | 2021-06-05 | Cisplatin | 02 | N | CISPLATIN | 100495310 |
| 190009200 | 190004840 | null | 72.4 | Palliative (P) | null | 2019-05-01 | CYCLOPHOSPHAMIDE + DOXORUBICIN + VINCRISTINE | null | null | CISPLATIN + RT | 100160406 |
| 190009204 | 190004841 | 1.8 | 106.8 | Palliative (P) | null | 2017-08-21 | Cisplatin 7 day | 02 | null | CISPLATIN | 101767591 |
| 190009210 | 190004843 | 1.43 | 45.5 | null | 2019-08-28 | 2019-09-18 | Cisplatin + Radiotherapy | 02 | N | CISPLATIN | 100052124 |
| 190009212 | 190004844 | 1.59 | 96.8 | null | 2016-11-30 | 2017-05-11 | Cisplatin + Radiotherapy | 02 | N | CISPLATIN | 101402106 |
| 190009215 | 190004845 | 0 | 36.1 | Palliative (P) | 2018-08-19 | 2018-12-31 | CARBOPLATIN | N | Y | CARBOPLATIN | 100645235 |
| 190009222 | 190004846 | 1.45 | 97.9 | Palliative (P) | 2018-03-08 | 2018-03-09 | Cisplatin + Radiotherapy | Y | N | CISPLATIN | 100383361 |
| 190009225 | 190004847 | 1.6 | 70 | null | 2018-05-30 | 2019-02-09 | Carboplatin + Paclitaxel (3 weekly) | 02 | N | CARBOPLATIN + PACLITAXEL | 101047087 |
| 190009226 | 190004848 | 1.71 | 62.5 | null | 2016-05-16 | 2016-05-20 | NB HRNBL-1 COJEC Ind COURSE B | null | N | TRIAL UNSPECIFIED | 101766662 |
| 190009227 | 190004849 | 1.63 | 66.6 | Palliative (P) | 2018-07-30 | 2018-08-17 | CARBOPLATIN + RT | 02 | N | CARBOPLATIN | 101626008 |
| 190009232 | 190004850 | 0 | 43 | Curative (C) | 2020-08-09 | 2021-02-06 | Capecitabine | 02 | N | CISPLATIN + GEMCITABINE | 100547903 |
| 190009237 | 190004851 | null | 73.2 | Palliative (P) | 2017-01-20 | 2017-01-27 | Carboplatin AUC 6 - 10 | 2 | Y | CARBOPLATIN | 101461415 |
| 190009242 | 190004852 | 1.73 | 53.5 | Palliative (P) | 2018-02-18 | 2018-09-09 | OCTREOTIDE | 02 | null | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | 100579455 |
| 190009251 | 190004853 | 0 | 64.9 | Palliative (P) | 2019-05-01 | 2019-05-25 | DACTINOMYCIN + CYCLO + VINCRISTINE | 02 | N | CISPLATIN + GEMCITABINE | 100686808 |
| 190009261 | 190004855 | 1.66 | 67.3 | Curative (C) | 2017-01-01 | 2017-09-12 | Cisplatin + Docetaxel +Fluorouracil | Y | N | FLUOROURACIL + IRINOTECAN | 101383045 |
| 190009262 | 190004856 | 1.62 | 97 | Palliative (P) | 2019-12-30 | 2019-12-31 | CARBOPLATIN + CYCLOPHOSPHAMIDE + ETOPOSIDE | 02 | N | PEMBROLIZUMAB | 100285155 |
| 190009265 | 190004857 | 1.72 | 64.65 | Adjuvant (A) | 2016-06-14 | 2017-01-19 | Carboplatin AUC 6 - 10 | N | N | CARBOPLATIN | 100275093 |
| 190009272 | 190004858 | 1.74 | 98.3 | Curative (C) | 2020-05-09 | 2020-05-09 | EW Rel rEECur Gemcitabine/Docetaxel + GCSF | 02 | N | CISPLATIN + RT | 100642078 |
| 190009281 | 190004859 | 1.84 | 74.5 | null | 2017-11-14 | 2018-02-21 | FLUOROURACIL + OXALIPLATIN | 02 | N | CAPECITABINE | 100240395 |
| 190009291 | 190004860 | 0 | 72.6 | Palliative (P) | 2020-07-15 | 2020-07-18 | Cisplatin + Radiotherapy | 01 | N | CISPLATIN | 100709712 |